Summary by Futu AI
The New York Stock Exchange has approved the listing and registration of a series of notes guaranteed by Merck & Co., Inc. These securities are issued by MSD Netherlands Capital B.V. and include 3.250% Notes due in 2032, 3.500% Notes due in 2037, 3.700% Notes due in 2044, and 3.750% Notes due in 2054. The approval by the NYSE is a significant step for Merck & Co., as it allows the company to expand its financial instruments in the market. The listing under the Exchange Act of 1934 was confirmed on May 30, 2024.